We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A...

Published on 29 May 2024 on Simply Wall St. via Yahoo Finance

We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A...

Key Insights

Sangamo Therapeutics will host its Annual General Meeting on 4th of JuneSalary of US$716.4k is part of CEO Sandy Macrae's total remunerationThe total compensation is 119% higher than the average for the industrySangamo Therapeutics' three-year loss to shareholders was 94% while its EPS was down 15% over the past three years

Read the rest of the article

NASDAQ.SGMO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Options run thin for Sangamo Therapeutics after Pfizer deal crashes - San...

Pfizer Inc. abruptly ended a key hemophilia A gene therapy collaboration with Sangamo Therapeutic...

The Business Journals 31 Dec 2024

Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends...

Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash...

Market Watch 31 Dec 2024

SGMO Pre-Market Shares Drop 40% Over Pfizer (PFE) Deal Collapse

Investors continued to sell off shares in Sangamo Therapeutics Inc. (NASDAQ:SGMO) before market o...

Insider Monkey · via Yahoo Finance 31 Dec 2024

Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug

(Bloomberg) -- Sangamo Therapeutics Inc. shares fell the most in 16 years after Pfizer Inc. ended...

Bloomberg · via Yahoo Finance 31 Dec 2024

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy...

On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercializatio...

Benzinga · via Yahoo Finance 31 Dec 2024

Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal By...

Sangamo Therapeutics Inc (NASDAQ:SGMO) announced on Monday that Pfizer (NYSE:PFE) has ended their...

Investing.com 31 Dec 2024

SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Sangamo...

Zacks · via Yahoo Finance 31 Dec 2024

Why Is Sangamo Therapeutics Inc. (SGMO) Among the Top CRISPR Stocks to Invest...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are goi...

Insider Monkey · via Yahoo Finance 31 Dec 2024

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic...

Upfront License Fees and Milestone Payments: Received $50 million from Genentech. Cash Runway:...

GuruFocus.com · via Yahoo Finance 13 Nov 2024

We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A...

Key Insights Sangamo Therapeutics will host its Annual General Meeting on 4th of JuneSalary of US...

Simply Wall St. via Yahoo Finance 29 May 2024

News

We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A...

NASDAQ.SGMO price evolution

Want to become a better investor?